Jun/17/2008 03:32
If
you believe that DTC serves a purpose, to inform
patients and consumers about treatment options and be
proactive in their healthcare choices, than the
agreement of some drug makers to limit DTC for new
products for six months after approval is a copout
and stinks of executives who are not willing to walk
the walk and talk the talk when it comes to DTC. This
is a bad agreement for everyone but perhaps the
biggest losers in this agreement are
consumers. Read
More...
May/31/2008 06:36
As
a student of law I have been watching the Vioxx cases
very carefully and scratching my head. One of the
first things you learn as a law student is that cases
are decided on facts. If opposing counsel brings
emotion into the courtroom it is our job to bring the
case down to the facts. It was therefore reassuring
to see that in Texas, the court's Chief Justice Adele
Hedges said there was "no evidence" that the patient
had suffered a cardiovascular event as the result of
a blood clot or that Vioxx was in any way related to
the death. Read
More...
